“Molecularly Modified Benzimidazole Derivatives: Rational Design and Antimicrobial Potentials for Next-Generation Therapeutics” (2026) Current Pharmaceutical Letters And Reviews, 2(1), pp. 01–19. doi:10.62896/cplr.3.1.01.